Pages
- 1
- 2
- Systems approach for classifying the response to biological therapies in patients with rheumatoid arthritis in clinical practice
- Weight loss predictability by plasma metabolic signatures in adults with obesity and morbid obesity of the DiOGenes study
- Application of a point of care creatinine device for trend monitoring in kidney transplant patients: Fit for purpose?
- Patient experiences with self-monitoring renal function after renal transplantation: results from a single-center prospective pilot study
- Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia
- Of monkeys and men: A metabolomic analysis of static and dynamic urinary metabolic phenotypes in two species
- Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival
- Skin and urine pentosidine weakly correlate with joint damage in a cohort of patients with early signs of osteoarthritis (CHECK)
- P-glycoprotein-deficient mice have proximal tubule dysfunction but are protected against ischemic renal injury
- Urinary pentosidine does not predict cartilage loss among subjects with symptomatic knee OA: The BOKS Study
- Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation
- Markers for Type II Collagen Breakdown Predict the Effect of Disease-Modifying Treatment on Long-Term Radiographic Progression in Patients with Rheumatoid Arthritis
- Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: A comparison with clinically used tumor markers
Pages
- 1
- 2